# Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients

> **NCT06651866** · PHASE1 · RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 18 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** D-CMG

## Key facts

- **NCT ID:** NCT06651866
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06651866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06651866, "Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06651866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*